Risk factors for male breast cancer (United States)

Cancer Causes and Control

Volumn 9, Issue 3, 1998, Pages 269-275

  Hsing, Ann W ^a   McLaughlin, Joseph K ^b   Cocco, Pierluigi ^a   Co Chien, Harvey T ^c   Fraumeni Jr , Joseph F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c WESTAT   (United States)

Author keywords

Alcohol; Diet; Male breast cancer; Obesity; Tobacco; United States

Indexed keywords

ADULT; ARTICLE; BODY MASS; BREAST CANCER; BREAST DISEASE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; DIET; EXERCISE; FAMILY HISTORY; GYNECOMASTIA; HUMAN; INTERVIEW; KLINEFELTER SYNDROME; MALE; MALE BREAST; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SOCIAL STATUS;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS, MALE; CASE-CONTROL STUDIES; DIET; EXERCISE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SOCIAL CLASS; UNITED STATES;

EID: 0031848964     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008869003012     Document Type: Article

References (43)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47: 5-27.
2. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlary J, Powell J. Cancer Incidence in Five Continents, Vol VI, Lyon, France: International Agency for Research on Cancer, 1992; IARC Sci. Pub. No. 120
3. Donegan WL. Cancer of the breast in men. CA Cancer J Clin 1991; 41: 339-54.
4. Thomas DB. Breast cancer in men. Epidemiol Rev 1993; 15: 22C-31.
5. Narod SA, Ford P, Devilee P, et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet 1995; 56: 254-64.
6. Stratton MR, Ford D, Neuhasen S, et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 1994; 7: 103-7.
7. Scheike O, Visfeldt J, Petersen B. Male breast cancer. Breast carcinoma in association with Klinefelter syndrome. Acta Pathol Microbiol Scand 1973; 81: 352-8.
8. Harnden DG, Maclean N, Langlands AO. Carcinoma of the breast and Klinefelter's syndrome. J Med Genet 1971; 8: 460-1.
9. D'Avanzo B, La Vecchia C. Risk factors for male breast cancer. Br J Cancer 1995; 71: 1359-462.
10. Sasco AJ, Cowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993; 53: 538-49.
11. Thomas D, Jimenez, LM, McTiernan A, et al. Breast cancer in men: Risk factors with hormonal implications. Am J Epidemiol 1992; 135: 734-48.
12. Rosenblatt KA, Thomas DB, McTiernan A, et al. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst 1991; 83: 849-54.
13. Lenfant-Pejovic M, Milka-Cabanne N, Bouchardy C, Auquier A. Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer 1990; 45: 662-5.
14. Rose DP. Endocrine epidemiology of male breast cancer. Anticancer Res 1988; 8: 845-50.
15. Casagrande JT, Hanisch R, Pike MC, Ross RK, Brown JB, Henderson BE. A case-control study of male breast cancer. Cancer Res 1988; 48: 1326-30.
16. Olsson H, Ranstam J. Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst 1988; 80: 679-83.
17. Mabuchi K, Bross ID, Kessler II. Risk factors for male breast cancer. J Natl Cancer Inst 1985; 74: 371-5.
18. Schottenfeld D, Lilienfeld AM. Some epidemiological features of breast cancer among males. J Chronic Dis 1973; 16: 71-81.
19. Thomas DB, Rosenblatt K, Jimenez LM, et al. Ionizing radiation and breast cancer in men (United States). Cancer Causes Control 1994; 5: 9-14.
20. Rosenbaum PF, Vena JE, Zielenzy MA, Michalek AM. Occupational exposures associated with male breast cancer. Am J Epidemiol 1994; 139: 30-6.
21. Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW. Electric power, pineal function, and the risk of breast cancer. FASEB J 1992; 6: 853-60.
22. Demers PA, Thomas DV, Rosenblatt KA, et al. Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol 1991; 134: 340-7.
23. Matanoski GM, Breysse PN, Elliott EA. Electromagnetic field exposure and male breast cancer. Lancet 1991; 337: 737.
24. Heath CW. Electromagnetic field exposure and cancer: A review of epidemiologic evidence. CA Cancer J Clin 1996; 46: 29-44.
25. Seeman A, Poe G, McLaughlin JK. Design of the 1986 National Mortality Followback Survey: consideration on collection data on decedents. Public Health Rep 1989; 104: 183-8.
26. Hsing AW, Hoover RN, McLaughlin JK, et al. Oral contraceptives and primary liver cancer among young women. Cancer Causes Control 1992; 3: 43-8.
27. Hsing AW, Nam JM, Co Chien H, McLaughlin JK, Fraumeni JF Jr. Risk factors for adrenal cancer: an exploratory study. Int J Cancer 1996; 65: 432-6.
28. World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO, 1977.
29. Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume 1, The Analysis of Case-control Studies. International Agency for Research on Cancer, Lyon, France: 1980; IARC Sci. Pub. No. 32.
30. Kelsey JL. Breast cancer epidemiology: Epidemiol Rev 1993; 15: 256-63.
31. Kirschner MA, Schneider G, Ertel HH, et al. Obesity, androgens, estrogens, and cancer risk. Cancer Res 1982; 42 (Suppl): 32815-44.
32. Schneider J, Bradlow HL, Strain G, Levin J, Anderson C, Fishman J. Effects of obesity on estradiol metabolism. Decreased formation of nonuterotropic metabolites. J Clin Endocrinol Metab 1983; 56: 973-8.
33. Ota DM, Jones LA, Jackson GL, Jackson PM, Kemp K, Bauman D. Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients. Cancer 1986; 57: 558-62.
34. Dao TL, Morreal C, Nemoto T. Urinary estrogen excretion in men with breast cancer. N Engl J Med 1973; 289: 138-40.
35. Nirmul D, Pegoraro RJ, Jiala I, Naidoo C, Joubert SM. The sex hormone profile of male patients with breast cancer. Br J Cancer 1982; 48: 423-7.
36. Calabresi E, DeGuili G, Becciolini A, et al. Plasma estrogens and androgens in male breast cancer. J Steroid Biochem 1976; 7: 605-9.
37. McLaughlin JK, Malker HS, Blot WJ, Weiner JA, Ericsson JLE, Fraumeni JF Jr. Occupational risks for male breast cancer in Sweden. Br J Ind Med 1988; 45: 275-6.
38. Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 1979; 48: 338.
39. Longnecker MP, Newcomb PA, Mittendorf R, Greenberg R. Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst 1995; 87: 923-9.
40. McLaughlin JK, Blot WJ, Mehl ES, Mandel JS. Problems in the use of dead controls in case-control studies: I. General results. Am J Epidemiol 1985; 121: 131-9.
41. McLaughlin JK, Blot WJ, Mehl ES, Mandel JS. Problems in the use of dead controls in case-control studies: II. Effect of excluding certain causes of death. Am J Epidemiol 1985; 122: 485-94.
42. Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. Atlanta, GA (USA): Department of Health and Human Services, 1989; DHHS Publ. No. (CDC) 89-8411.
43. Smith AH, Pearce N, Cellas PW. Cancer case-control studies with other cancers as controls. Int J Epidemiol 1988; 17: 298-306.